These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19732168)

  • 21. National Patterns of Commonly Prescribed Psychotropic Medications to Young People.
    Sultan RS; Correll CU; Schoenbaum M; King M; Walkup JT; Olfson M
    J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):158-165. PubMed ID: 29376743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of medication by young people with attention-deficit/hyperactivity disorder.
    Sawyer MG; Rey JM; Graetz BW; Clark JJ; Baghurst PA
    Med J Aust; 2002 Jul; 177(1):21-5. PubMed ID: 12088474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
    Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
    [No Abstract]   [Full Text] [Related]  

  • 24. Consequences of ADHD medication use for children's outcomes.
    Dalsgaard S; Nielsen HS; Simonsen M
    J Health Econ; 2014 Sep; 37():137-51. PubMed ID: 24997381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Age, Gender, and Living Circumstances on Patterns of Attention-Deficit/Hyperactivity Disorder Medication Use in Children and Adolescents With or Without Intellectual Disabilities.
    Osunsanmi S; Turk J
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):828-834. PubMed ID: 26982546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Explaining racial and ethnic differences in children's use of stimulant medications.
    Hudson JL; Miller GE; Kirby JB
    Med Care; 2007 Nov; 45(11):1068-75. PubMed ID: 18049347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulant medication use in children: a 12-year perspective.
    Zuvekas SH; Vitiello B
    Am J Psychiatry; 2012 Feb; 169(2):160-6. PubMed ID: 22420039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age, academic performance, and stimulant prescribing for ADHD: a nationwide cohort study.
    Zoëga H; Valdimarsdóttir UA; Hernández-Díaz S
    Pediatrics; 2012 Dec; 130(6):1012-8. PubMed ID: 23166340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulants in AD/HD, a controversial treatment only in Sweden?
    Ekman JT; Gustafsson PA
    Eur Child Adolesc Psychiatry; 2000 Dec; 9(4):312-3. PubMed ID: 11202108
    [No Abstract]   [Full Text] [Related]  

  • 30. Sociodemographic and economic comparisons of children prescribed longer-acting versus short-acting stimulant medications for attention deficit hyperactivity disorder.
    Stevens J; Harman JS; Kelleher KJ
    J Behav Health Serv Res; 2005; 32(4):430-7. PubMed ID: 16215451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Palli SR; Kamble PS; Chen H; Aparasu RR
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
    Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
    J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social adversity and regional differences in prescribing of ADHD medication for school-age children.
    Wallach-Kildemoes H; Skovgaard AM; Thielen K; Pottegård A; Mortensen LH
    J Dev Behav Pediatr; 2015 Jun; 36(5):330-41. PubMed ID: 25997081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children: Child and Adolescent Psychiatrists' Adherence to Clinical Practice Guidelines.
    Chung J; Tchaconas A; Meryash D; Adesman A
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):335-43. PubMed ID: 27105063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prevalence of Stimulant and Antidepressant Use by Australian Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: A National Survey.
    Sawyer MG; Reece CE; Sawyer AC; Johnson S; Lawrence D; Zubrick SR
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):177-184. PubMed ID: 27154239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
    Babinski DE; Waxmonsky JG; Waschbusch DA; Humphery H; Pelham WE
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National trends in the treatment of attention deficit hyperactivity disorder.
    Olfson M; Gameroff MJ; Marcus SC; Jensen PS
    Am J Psychiatry; 2003 Jun; 160(6):1071-7. PubMed ID: 12777264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of health care services and psychotropic medication in a community sample of 9-year-old schoolchildren with ADHD.
    Tremmery S; Buitelaar JK; Steyaert J; Molenberghs G; Feron FJ; Kalff AC; Hurks PP; Hendriksen JG; Vles JS; Jolles J
    Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):327-36. PubMed ID: 17636356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.